Logo-aim
Arch Iran Med. 2023;26(4): 229-233.
doi: 10.34172/aim.2023.35
PMID: 38301084
PMCID: PMC10685747
  Abstract View: 803
  PDF Download: 469

Brief Report

Cohort Profile: Shiraz Pediatric Liver Cirrhosis Cohort (SPLCCS)

Nasrin Motazedian 1 ORCID logo, Bita Geramizadeh 1, Seyed Mohsen Dehghani 1, Negar Azarpira 1* ORCID logo, Mahdokht Hossein Aghdaei 1, Ramin Yaghobi 1, Alireza Shamsaeefar 2, Kourosh Kazemi 2, Mohammad Hossein Karimi 1, Alireza Mirahmadizadeh 3, Amirali Mashhadiagha 1,4, Maryam Ataollahi 5, Homa Ilkhanipoor 5, Mitra Basiratnia 5, Hamid Nemati 5, Maryam Ekramzadeh 6, Anahita Sanaei Dashti 5, Saman Nikeghbalian 2, Seyed Ali Malekhosseini 2

1 Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Abu Ali Sina Organ Transplant Center, Shiraz University of Medical Sciences, Shiraz, Iran
3 Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
5 Pediatric Department, Shiraz University of Medical Sciences, Shiraz, Iran
6 Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
*Corresponding Author: Negar Azarpira, , Email: negarazarpira@yahoo.com

Abstract

Liver diseases in children and adolescents are a significant and arising public health issue and should be surveyed from different dimensions (clinical and para-clinical, psychological, socio-economic) and in diverse populations. Shiraz Liver Transplant Center, Shiraz, Iran is the only center for pediatric liver transplantation and its pre-operative evaluations. This provides a unique and valuable situation for studying this vulnerable population. The Shiraz Pediatric Liver Cirrhosis Cohort Study (SPLCCS) was established to assess cirrhotic children, the course of their disease, and treatment over time. This cohort study aimed to prospectively evaluate the natural course and factors that contributed to complications and death of children with chronic liver disease in the region. SPLCCS was launched in September 2018 after obtaining ethical approval; until August 2022, 370 children with end-stage liver disease were enrolled and followed every six months. Here, the cohort’s features, the included population’s baseline characteristics, and primary outcomes are reported.

Cite this article as: Motazedian N, Geramizadeh B, Dehghani SM, Azarpira N, Hossein Aghdaei M, Yaghobi R, et al. Cohort profile: Shiraz pediatric liver cirrhosis cohort (SPLCCS). Arch Iran Med. 2023;26(4):229-233. doi: 10.34172/aim.2023.35
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 804

Your browser does not support the canvas element.


PDF Download: 469

Your browser does not support the canvas element.

Submitted: 25 Sep 2022
Revision: 21 Jan 2023
Accepted: 23 Jan 2023
ePublished: 01 Apr 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)